Clinical Trial Update: Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy [NA]

View source ↗

Summary

A clinical trial evaluating a novel dabigatran-based peri-operative bridging protocol for patients on chronic warfarin therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Pradaxa (dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Venous Thromboses | NA | Status: WITHDRAWN